Loading...
Bangkok Dusit Medical Services Public Company Limited
BDULF•PNK
Healthcare
Medical - Care Facilities
$0.61
$0.00(0.00%)
Bangkok Dusit Medical Services Public Company Limited (BDULF) Financial Performance & Statements
Review Bangkok Dusit Medical Services Public Company Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.96%
↑ 6.96%
Operating Income Growth
8.33%
↑ 8.33%
Net Income Growth
11.21%
↑ 11.21%
Operating Cash Flow Growth
10.49%
↑ 10.49%
Operating Margin
19.05%
↑ 19.05%
Gross Margin
36.88%
↑ 36.88%
Net Profit Margin
14.87%
↑ 14.87%
ROE
16.34%
↑ 16.34%
ROIC
15.51%
↑ 15.51%
Bangkok Dusit Medical Services Public Company Limited (BDULF) Financial Statements
Explore quarterly and annual reports for Bangkok Dusit Medical Services Public Company Limited stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $27.40B | $28.15B | $25.70B | $26.61B |
| Cost of Revenue | $17.04B | $17.63B | $16.66B | $16.74B |
| Gross Profit | $10.37B | $10.52B | $9.04B | $9.87B |
| Gross Profit Ratio | $0.38 | $0.37 | $0.35 | $0.37 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.48B | $5.31B | $5.15B | $4.89B |
| Operating Expenses | $5.04B | $4.91B | $4.77B | $4.89B |
| Total Costs & Expenses | $22.08B | $22.54B | $21.81B | $21.63B |
| Interest Income | $39.02M | $40.17M | $47.46M | $48.15M |
| Interest Expense | $107.87M | $102.42M | $110.56M | $112.54M |
| Depreciation & Amortization | $1.60B | $1.55B | $1.50B | $1.48B |
| EBITDA | $6.99B | $7.22B | $5.82B | $6.83B |
| EBITDA Ratio | $0.26 | $0.26 | $0.23 | $0.26 |
| Operating Income | $5.32B | $5.61B | $4.27B | $4.98B |
| Operating Income Ratio | $0.19 | $0.20 | $0.17 | $0.19 |
| Other Income/Expenses (Net) | -$43.68M | -$38.33M | -$49.05M | -$64.39M |
| Income Before Tax | $5.28B | $5.57B | $4.22B | $5.25B |
| Income Before Tax Ratio | $0.19 | $0.20 | $0.16 | $0.20 |
| Income Tax Expense | $840.60M | $1.15B | $756.08M | $1.04B |
| Net Income | $4.33B | $4.25B | $3.33B | $4.07B |
| Net Income Ratio | $0.16 | $0.15 | $0.13 | $0.15 |
| EPS | $0.27 | $0.27 | $0.21 | $0.26 |
| Diluted EPS | $0.27 | $0.27 | $0.21 | $0.26 |
| Weighted Avg Shares Outstanding | $15.89B | $15.89B | $15.89B | $15.89B |
| Weighted Avg Shares Outstanding (Diluted) | $15.89B | $15.89B | $15.89B | $15.89B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan